Liver Transplantation for Metabolic Liver Diseases

Clinics in Liver Disease

Volumn 11, Issue 2, 2007, Pages 265-281

  Zhang, Kristine Y ^a   Tung, Bruce Y ^a   Kowdley, Kris V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; CYSTIC FIBROSIS; FAMILIAL AMYLOID POLYNEUROPATHY; HEMOCHROMATOSIS; HUMAN; LIVER DISEASE; LIVER GRAFT; LIVER TRANSPLANTATION; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; REVIEW; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES;

ALPHA 1-ANTITRYPSIN DEFICIENCY; AMYLOID NEUROPATHIES, FAMILIAL; CYSTIC FIBROSIS; HEMOCHROMATOSIS; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION;

EID: 34250843965     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2007.04.002     Document Type: Review

References (111)

1. Belle S.H., Beringer K.C., and Detre K.M. Liver transplantation in the United States: results from the national Pitt-UNOS liver transplant registry. Clin Transpl (1994) 19-35
2. Holme E., and lindstedt S. Tyrosinaemia type I and NTBC (2-(2-nitro-4trifluro-methybenzoyl)-1,3-cyclohexanedione). J Inherit Metab Dis 21 (1998) 507-517
3. Mohan N., McKiernan P., and Preece M.A. Indications and outcome of liver transplantation in tyrosinaemia type I. Eur J Pediatr 159 Suppl 2 (1999) S49-S54
4. Murace M., and Burlina A.B. Liver and liver cell transplantation for glycogen storage disease type IA. Acte Gastroenterol Belg 68 4 (2005) 469-472
5. Lee P.J., Muiesan P., and Heaton N. Successful pregnancy after combined renal-hepatic transplantation in glycogen storage disease type 1A. J Inherit Metab Dis 27 4 (2004) 537-538
6. Selby R., Starzl T.E., Yunis E., et al. Liver transplantation for type I and type IV glycogen storage disease. N Engl J Med 324 (1991) 39-42
7. Matern D., Starzl T.E., and Arnaout W. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 158 Suppl 2 (1999) s43-s58
8. Otto G., Herfarth C., and Snninger N. Hepatic transplantation in galactosemia. Transplantation 47 (1989) 902-903
9. Emond J.C., and Whitington P.F. Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease). Journal of Paediatric Surgery 30 (1995) 1635-1641
10. Bassas A., Chehab M., and Hebby H. Living related liver transplantation in 13 cases of progressive familial intraheptic cholestasis. Liver Transpl 35 8 (2003) 3003-3005
11. Torri E., Lucianetti A., and Pinelli D. Orthotopic liver transplantation for Byler's disease. Transplant Proc 37 2 (2005) 1149-1150
12. Marino I.R., ChapChap P., and Esquivel C.O. Liver transplantation for arteriohepatic dysplasia (Alagille's syndrome). Transplant Proc 5 2 (1992) 61-64
13. Maldini G., Torri E., and Lucianetti A. Orthotopic liver transplantation for Alagille syndrome. Transplant Proc 37 2 (2005) 1174-1176
14. Rodrigues F., Kallas M., and Nash R. Neonatal hemochromatosis-medical treatment vs transplantation: the king's experience. Liver Transpl 11 11 (2005) 1417-1424
15. Jamieson N.V. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group. J Nephrol 11 Suppl 1 (1998) 36-41
16. Schauer R., Stangl M., and Lang T. Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation. J Pediatr Surg 38 8 (2003) 1227-1231
17. Van der Veere C.N., Snnasappel M., McDonagh A.F., et al. Current therapy for Crigler-Najjar syndrome type I: report of a world registry. Hepatology 24 2 (1996) 311-315
18. Shrotri M., Fernando B.S., and Sudhindran S. Long-term outcome of liver transplantation for familial hypercholesterolemia. Transplant Proc 35 1 (2003) 381-382
19. Barbir M., Khaghani A., and Kehely A. Normal levels of lipoproteins including lipoprotein(a) after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia. Q J Med 95 (1992) 807-812
20. Whitington P.F., Alonso E.M., and Boyle J.T. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 21 Suppl 1 (1998) 112-118
21. Gordon F.H., Mistry P.K., and Sabin A. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut 42 5 (1998) 744-749
22. Smanik E.J., Tavill A.S., Jacobs G.H., et al. Orthotopic liver transplantation in two adults with Niemann-Pick and Gaucher's diseases: implications for the treatment of inherited metabolic liver disease. Hepatology 17 1 (1993) 42-49
23. DuCerf C., Bancel B., Caillon P., et al. Orthotopic liver transplantation for type 1 Gaucher's disease. Tranplantation 53 (1992) 1141-1143
24. Carlson D.E., Busuttil R.W., Giudici T.A., et al. Orthotopic liver transplantation in the treatment of complications of type 1 Gaucher's disease. Tranplantation 49 (1990) 1192-1194
25. Doss M.O., and Frank M. Hepatobiliary implications and complications in protophorphyria, a 20-year study. Clin Biochem 22 3 (1989) 223-229
26. Bloomer J.R., Rank J.M., and Payne W.D. Follow-up after liver transplantation for protoporphyric liver disease. Liver Transpl Surg 2 (1996) 269-275
27. McGuire B.M., Bonkovsky H.L., and Carithers R.L. Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl 11 12 (2005) 1590-1596
28. Olivarez L., Caggana M., and Pass K.A. Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach. Ann Hum Genet 65 (2001) 459-463
29. Forbes J.R., and Cox D.W. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins. Hum Mol Genet 9 (2000) 1927-1935
30. Bull P.C., Thomas G.R., and Rommens J.M. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5 (1993) 327-337
31. Danks D.M., Metz G., Sewell R., et al. Wilson's disease in adults with cirrhosis but no neurological abnormalities. Br Med J 301 (1990) 331-332
32. Brewer G.J., Fink J.K., and Hedera P. Diagnosis and treatment of Wilson's disease. Semin Neurol 19 (1999) 261-270
33. Sternlieb I. Wilson's disease: indications for liver transplants. Hepatology 4 (1984) 15S-17S
34. Carithers R.L., and Murray K.F. AASLD practice guidelines: evaluations of the patient for liver transplantation. Heptology 41 6 (2005) 1407-1432
35. Bellary S., Hassanein T., and Van-Thiel D.H. Liver transplantation for Wilson's disease. J Hepatol 23 (1995) 373-381
36. Eghtesad B., Nezakatgoo N., Geraci L.C., et al. Liver transplantation for Wilson's disease: a single-center experience. Liver Transpl 5 6 (1999) 467-474
37. Emre S., Atillasoy E.O., Ozdemir S., et al. Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation 72 (2001) 1232-1236
38. Asonuma K., Inomata Y., Kasahara M., et al. Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease. Pediatr Transplant 3 3 (1999) 201-205
39. Chen C.L., Chen Y.S., Lui C.C., et al. Neurological improvement of Wilson's disease after liver transplantation. Transplant Proc 29 (1997) 497-498
40. Mason A.L., Marsh W., and Alpers D.H. Intractable neurological Wilson's disease treated with orthotopic liver transplantation. Dig Dis Sci 38 (1993) 1746-1750
41. Bax R.T., Hassler A., Luck W., et al. Cerebral manifestation of Wilson's disease successfully treated with liver transplantation. Neurology 51 (1998) 863-865
42. Marcus N., Techman J.H., and Perlmutter D.H. Alpha 1-antitrypsin deficiency: from genotype to childhood disease. J Pediatr Gastroenterol Nutr 27 (1998) 65-74
43. Perlmutter D.H. Clinical manifestations of alpha(1)-antitrypsin deficiency. Gastroenterol Clin North Am 24 (1995) 27-43
44. Silverman E.K., Miletich J.P., Pierce J.A., et al. α1-antitrypsin deficiency. High prevalence in the St Louis area determined by direct population screening. Am Rev Respir Dis 140 (1989) 961-966
45. Sveger T., and Eriksson S. The liver in adolescents with α1-antitrypsin deficiency. Hepatology 22 (1995) 514-517
46. Vennarecci G., Gunson B.K., Ismail T., et al. Transplantation for end stage liver disease related to α1-antitrypsin. Transplantation 61 (1996) 1488-1495
47. Rabin V.S., Watson M., Kidd V., et al. Regional location of α1-antichymotrypsin and α1-antitrypsin genes on human chromosome 14. Somat Cell Mol Genet 12 (1986) 209-214
48. Triger D.R., Millward-Sadler G.H., Czaykowski A.A., et al. Alpha-1 antitrypsin deficiency and liver disease in adults. Q J Medicine (New Series, XLV) 178 (1976) 351-372
49. Moroz S.P. Liver disease associated with α1-antitrypsin deficiency in childhood. J Pediatr Gastroenterol Nutr 88 (1976) 19-25
50. Sveger T. Liver disease in α1-antitrypsin deficiency detected by screening in 200,000 infants. N Engl J Med 294 (1976) 1316-1321
51. Ibarguen E. Liver disease in α1-antitrypsin deficiency and prognostic indicators. J Pediatr Gastroenterol Nutr 117 (1990) 864-870
52. Filipponi F., Soubrane O., Labrousse F., et al. Liver transplantation for end stage liver disease associated with α1-antitrypsin deficiency in children: pretransplant natural history, timing, and results of transplantation. J Heptatol 21 1 (1994) 72-78
53. Esquivel C.O., Vicente E., Van-Thiel D., et al. Orthotopic liver transplantation for α1-antitrypsin deficiency: an experience in 29 children and ten adults. Transplant Proc 19 5 (1987) 3798-3802
54. Gishan F.K. α1-antitrypsin deficiency presenting with ascites and cirrhosis in the neonatal period. Gastroenterology 85 (1983) 435-438
55. Perlmutter D.H. α1-antitrypsin deficiency: diagnosis and treatment. Clin Liver Dis 8 (2004) 839-859
56. Eriksson S., Carlson J., and Velez R. Risk of cirrhosis and primary liver cancer in α1-antitrypsin deficiency. N Engl J Med 314 12 (1986) 736-739
57. Herlenius G., Wilczek H.E., Larsson M., et al. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the familial amyloidotic polyneuropathy world transplant registry. Transplantation 77 1 (2004) 64-71
58. Monteiro E., Freire A., and Barroso E. Familial amyloid polyneuropathy and liver transplantation. J Hepatol 41 (2004) 188-194
59. Holmgren G., Haettner E., Nordenson I., et al. Homozygosity for the transthyretin-met30-gene in two Swedish sibs with familial amyloidotic polyneuropathy. Clin Genet 34 (1988) 333-338
60. Adams D., Samuel D., Goulon-Goeau C., et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123 (2000) 1495-1504
61. Monteiro E., Perdigoto R., and Furtado A.L. Liver transplantation for familial amyloid polyneuropathy. Hepatogastroenterology 45 23 (1998) 1375-1380
62. Furtado A., Tome L., Oliveira F.J., et al. Sequential liver transplantation. Transplant Proc 29 (1997) 467-468
63. DuBois S., and Kowdley K.V. Review article: targeted screening for hereditary haemochromatosis in high-risk groups. Aliment Pharmocol Ther 20 (2004) 1-14
64. Feder J.N., Guirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 (1996) 399-408
65. Bacon B.R., Powell L.W., Adams P.C., et al. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 116 (1999) 193-207
66. Fargion S., Mandelli C., Peiperno A., et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 15 (1992) 655-659
67. Niederau C., Fischer R., Purschel A., et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110 (1996) 1107-1109
68. Kilpe V.E., Krakauer H., and Wren R.E. An analysis of liver transplant experience from 37 transplant centers as reported to medicare. Transplantation 56 (1993) 554-561
69. Deugnier Y., Turlin B., le Quilleuc D., et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis practical implications for the diagnosis of hemochromatosis. Am J Sug Pathol 21 (1997) 669-675
70. Brandhagen D.J., Alvarez W., Therneau T.M., et al. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology 31 (2000) 456-460
71. Kowdley K.V., Brandhagen D.J., Gish R.G., et al. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology 129 2 (2005) 494-503
72. Powell L.W. Hemochromatosis: the impact of early diagnosis and therapy. Gastroenterology 110 4 (1996) 1304-1307
73. Kowdley K.V., Hassanein T., Kaur S., et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg 1 (1995) 237-241
74. Tung B.Y., Farrell F.J., McCashland T.M., et al. Long-term follow-up after liver transplantation in patients with hepatic iron overload. Liver Transpl Surg 5 5 (1999) 369-374
75. Farrell F.J., Nguyen M., Woodley S., et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology 20 (1994) 404-410
76. Crawford D.H.G., Fletcher L.M., Hubscher S.G., et al. Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis. Hepatology 39 (2004) 1655-1662
77. Bralet M.P., Duclos-Vallee J.C., Castaing D., et al. No hepatic iron overload 12 years after liver transplantation for hereditary hemochromatosis. Hepatology 40 (2004) 762
78. Kowdley K.V. Liver transplantation: an "in vivo" model for the pathophysiology of hemochromatosis?. Hepatology 39 (2004) 1495-1498
79. Wanless I.R., and Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12 (1990) 1106-1110
80. Dioxn J.B., Bhathal P.S., and O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 1 (2001) 91-100
81. Powell E.E., Cooksley W.G., Hanson R., et al. The natural history of nonalcoholic steatohepatitis: a follow up study of forty-two patients for up to 21 years. Hepatology 11 (1990) 74-80
82. Evans C.D., Oien K.A., MacSween R.N., et al. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?. J Clin Pathol 55 (2002) 689-692
83. Adams L.A., Keach J.C., Batts K., et al. Time course of fibrosis progression in patients with nonalcoholic fatty liver disease. Hepatology 38 (2003) 206A-207A
84. Ortiz V., Berenguer M., Rayon J.M., et al. Contribution of obesity to hepatitis C-related fibrosis progression. Am J Gastoenterol 97 (2002) 2408-2414
85. Hui J.M., Kenth J.G., Chitturi S., et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38 2 (2003) 420-427
86. Ioannou G.N., Weiss N.S., Kwodley K.V., et al. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population based cohort study. Gastroenterology 125 (2003) 1053-1105
87. Liver transplant waiting list. UNOS database 2000. Available at: http://www.optn.org/.
88. Cantos M.J., Cales W., Sterling R.K., et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 7 (2001) 363-373
89. Caldwell S.H., Oelsner D.H., Lezzoni J.C., et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29 (1999) 664-669
90. Poonawala A., Nair S.P., Thuluvath P.J., et al. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case control study. Hepatology 32 (2000) 689-693
91. Kotlyer D.S., Campbell M.S., Reddy K.R., et al. Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol 101 (2006) 1370-1378
92. Charlton M.C., Kasparova P., Weston S., et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 7 7 (2001) 608-614
93. Burke A., and Lucey M.R. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 4 5 (2004) 686-693
94. Neuschwander-Tetri B.A., Brunt E., Wehmeier K.R., et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 38 (2003) 1008-1017
95. Promrat K., Lutchman G., Uwaifo G.I., et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 39 1 (2004) 188-196
96. Colombo C., Russo M.C., Zazzeron L., et al. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr 43 1 (2006) S49-S55
97. Cohn J.A., Strong T.V., Picciotto M.R., et al. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 105 (1993) 1857-1864
98. Maurage C., Lenaerts C., Weber A.M., et al. Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis. J Pediatr Gastroenterol Nutr 9 (1989) 17-20
99. Feranchak A.P., and Sokol R.J. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis 21 (2001) 471-488
100. Colombo C.B.P., and Podda M. Hepatobiliary disease in cystic fibrosis. Semin Liver Dis 14 (1994) 259-269
101. Colombo C., Battezzati P.M., Crosignani A., et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 36 (2002) 1374-1382
102. Duthie A., Doherty D.G., William C., et al. Genotype analysis for F508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease. Hepatology 15 (1992) 660-664
103. Lamireau T., Monnereau S., Martin S., et al. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol 41 6 (2004) 920-925
104. Feigelson J., Anagnostopoulos C., Poguet M., et al. Liver cirrhosis in cystic fibrosis-the therapeutic implications and long term follow up. Arch Dis Child 68 (1993) 653-657
105. Gooding I., Dondos V., Gyi K.M., et al. Variceal hemorrhage and cystic fibrosis: outcomes and implications for liver transplantation. Liver Transpl 11 (2005) 1522-1526
106. Colombo C., Crosignani A., Rocchi A., et al. Effects of liver transplantation on the nutritional status of patients with cystic fibrosis. Transpl Int 18 (2005) 246-255
107. Milkiewicz P., Skiba G., Kelly D., et al. Transplantation for cystic fibrosis outcome following early liver transplantation. J Gastroenterol Hepatol 17 (2002) 208-213
108. Noble-Jamieson G., Valente J., Barnes N.D., et al. Liver transplantation for hepatic cirhosis in cystic fibrosis. Arch Dis Child 71 (1994) 349-352
109. Chaves-Cartaya R., Drage M., and Jamieson N.V. Biliary complications in liver transplantation for cystic fibrosis. Transplant Proc 31 6 (1999) 2411-2412
110. Couetil J.P., Soubrane O., Houssin D.P., et al. Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children. Transpl Int 10 1 (1997) 33-39
111. Mack D.R., Traystman M.D., Colombo J.L., et al. Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis. J Pediatr 127 (1995) 881-887